Multi-centre, double-blinded, randomised controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery.

Eshan Senanayake; Neil Howell; Aaron Ranasinghe; Nigel Edward Drury; Nick Freemantle; Michael P. Frenneaux; T Oelofse; David H. Green; Ian C. Wilson; Stephen J. Rooney; Jorge Mascaro; Timothy R. Graham; Sunil Bhudia; Michael E. Lewis; Domenico Pagano

Multi-centre, double-blinded, randomised controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery.

Eshan Senanayake
, Neil Howell
, Aaron Ranasinghe
, Nigel Edward Drury
, Nick Freemantle
, Michael P. Frenneaux
, T Oelofse
, David H. Green
, Ian C. Wilson
, Stephen J. Rooney
, Jorge Mascaro
, Timothy R. Graham
, Sunil Bhudia
, Michael E. Lewis
, Domenico Pagano

Research output: Contribution to conference (unpublished) › Abstract › peer-review

Original language	English
Publication status	Published - Mar 2014
Event	Society for Cardiothoracic Surgery Annual Meeting 2014 - Edinburgh, United Kingdom Duration: 16 Mar 2014 → …

Conference

Conference	Society for Cardiothoracic Surgery Annual Meeting 2014
Abbreviated title	SCTS 2014
Country/Territory	United Kingdom
City	Edinburgh
Period	16/03/14 → …

Cite this

Senanayake, E., Howell, N., Ranasinghe, A., Drury, N. E., Freemantle, N., Frenneaux, M. P., Oelofse, T., Green, D. H., Wilson, I. C., Rooney, S. J., Mascaro, J., Graham, T. R., Bhudia, S., Lewis, M. E., & Pagano, D. (2014). Multi-centre, double-blinded, randomised controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery.. Abstract from Society for Cardiothoracic Surgery Annual Meeting 2014, Edinburgh, United Kingdom.

@conference{8edb935d03e64b35a6f46d9cc5111db3,

title = "Multi-centre, double-blinded, randomised controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery.",

author = "Eshan Senanayake and Neil Howell and Aaron Ranasinghe and Drury, \{Nigel Edward\} and Nick Freemantle and Frenneaux, \{Michael P.\} and T Oelofse and Green, \{David H.\} and Wilson, \{Ian C.\} and Rooney, \{Stephen J.\} and Jorge Mascaro and Graham, \{Timothy R.\} and Sunil Bhudia and Lewis, \{Michael E.\} and Domenico Pagano",

year = "2014",

month = mar,

language = "English",

note = "Society for Cardiothoracic Surgery Annual Meeting 2014, SCTS 2014 ; Conference date: 16-03-2014",

}

Senanayake, E, Howell, N, Ranasinghe, A, Drury, NE, Freemantle, N, Frenneaux, MP, Oelofse, T, Green, DH, Wilson, IC, Rooney, SJ, Mascaro, J, Graham, TR, Bhudia, S, Lewis, ME & Pagano, D 2014, 'Multi-centre, double-blinded, randomised controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery.', Society for Cardiothoracic Surgery Annual Meeting 2014, Edinburgh, United Kingdom, 16/03/14.

Multi-centre, double-blinded, randomised controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery. / Senanayake, Eshan; Howell, Neil; Ranasinghe, Aaron et al.
2014. Abstract from Society for Cardiothoracic Surgery Annual Meeting 2014, Edinburgh, United Kingdom.

Research output: Contribution to conference (unpublished) › Abstract › peer-review

TY - CONF

T1 - Multi-centre, double-blinded, randomised controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery.

AU - Senanayake, Eshan

AU - Howell, Neil

AU - Ranasinghe, Aaron

AU - Drury, Nigel Edward

AU - Freemantle, Nick

AU - Frenneaux, Michael P.

AU - Oelofse, T

AU - Green, David H.

AU - Wilson, Ian C.

AU - Rooney, Stephen J.

AU - Mascaro, Jorge

AU - Graham, Timothy R.

AU - Bhudia, Sunil

AU - Lewis, Michael E.

AU - Pagano, Domenico

PY - 2014/3

Y1 - 2014/3

M3 - Abstract

T2 - Society for Cardiothoracic Surgery Annual Meeting 2014

Y2 - 16 March 2014

ER -

Senanayake E, Howell N, Ranasinghe A, Drury NE, Freemantle N, Frenneaux MP et al.. Multi-centre, double-blinded, randomised controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery.. 2014. Abstract from Society for Cardiothoracic Surgery Annual Meeting 2014, Edinburgh, United Kingdom.